Neuland Laboratories informs about outcome of board meeting

22 Nov 2017 Evaluate

Neuland Laboratories has informed about the Board of Directors at their meeting held on November 22, 2017, has approved the Unaudited financial results and limited review report by the auditors for the quarter ended September 30, 2017; and the appointment of Amit Agarwal as the Chief Financial officer (CFO) of the Company in place of D. Saharsh Rao with effect from November 22, 2017.  D.Saharsh Rao shall continue in his role as the Joint Managing Director of the Company.

The above information is a part of company’s filings submitted to BSE.

Neuland Laboratories Share Price

13611.80 443.95 (3.37%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×